"Leukemia, Lymphoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
Descriptor ID |
D007945
|
MeSH Number(s) |
C04.557.337.428 C15.604.515.560 C20.683.515.528
|
Concept/Terms |
Leukemia, Lymphoid- Leukemia, Lymphoid
- Leukemias, Lymphoid
- Lymphoid Leukemias
- Lymphocytic Leukemia
- Lymphoid Leukemia
- Leukemia, Lymphocytic
- Leukemias, Lymphocytic
- Lymphocytic Leukemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Lymphoid".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Lymphoid".
This graph shows the total number of publications written about "Leukemia, Lymphoid" by people in this website by year, and whether "Leukemia, Lymphoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2004 | 2 | 0 | 2 |
2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Lymphoid" by people in Profiles.
-
Cerny J, Yu H, Miron PM. Novel FGFR3 rearrangement t(4;22)(p16;q11.2) in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma. Ann Hematol. 2013 Oct; 92(10):1433-5.
-
Letai A, Sorcinelli MD, Beard C, Korsmeyer SJ. Antiapoptotic BCL-2 is required for maintenance of a model leukemia. Cancer Cell. 2004 Sep; 6(3):241-9.
-
Cerny J, Slavickova A, Krepelova A, Trneny M, Karban J, Klener P. Biallelic IgH rearrangements in patients with indolent lymphoproliferative disorders: molecular and practical implications. J Cell Physiol. 2004 May; 199(2):217-26.
-
Mi Q, Cui B, Ch?vez D, Chai H, Zhu H, Cordell GA, Hedayat S, Kinghorn AD, Pezzuto JM. Characterization of tropane alkaloid aromatic esters that reverse the multidrug-resistance phenotype. Anticancer Res. 2002 May-Jun; 22(3):1385-97.
-
Semple JW, Freedman J. Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia. Transfus Med Rev. 1995 Oct; 9(4):327-38.
-
Salisbury JL, Baron AT, Keller GA, Skiest D. Membrane IgM: interactions with the cortical cytoskeleton in the human lymphoblastoid cell line WiL2. Cell Motil Cytoskeleton. 1988; 9(2):140-52.
-
Garvey MB, Freedman J. Indirect platelet radioactive antiglobulin test in patients with lymphoproliferative disease. J Lab Clin Med. 1986 Feb; 107(2):123-8.
-
Forman SJ, Nathwani BN, Woda BA, Paladugu RR, Farbstein MJ. Clonal evolution of T-cell prolymphocytic leukemia to a T-large-cell lymphoma. A morphologic and immunologic study. Arch Pathol Lab Med. 1985 Dec; 109(12):1081-4.
-
Fox RI, Hueniken M, Fong S, Behar S, Royston I, Singhal SK, Thompson L. A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states. J Immunol. 1983 Aug; 131(2):762-7.
-
Bell R, Lillquist A, Abelson H, McCaffrey R. Chromatographic forms of terminal deoxynucleotidyl transferase in normal lymphoid cells and in leukemia cells at presentation and relapse. Leuk Res. 1982; 6(6):775-80.